Expansion of the GLP-1 market and the need for verified telehealth

The demand for GLP-1-based obesity treatments, such as Semaglutide and Tirzepatide, has surged recently, leading to explosive growth in the online telehealth market. However, concerns about side effects and patient safety are increasing due to the lack of clinical safeguards in unregulated distribution channels and indiscriminate prescriptions. Meant Health aims to address these concerns by offering a reliable clinical supervision system, going beyond simple drug delivery to establish itself as a trusted and professional provider.

Strengthening clinical rigor through collaboration with OpenLoop Health

Meant Health does not provide diagnoses or prescriptions directly but partners with OpenLoop Health, a specialized virtual medical infrastructure company, to deliver medical services. Licensed healthcare professionals at OpenLoop Health thoroughly review patients' medical history and online self-assessment questionnaires to determine the appropriateness of prescriptions. This approach differentiates Meant Health from existing low-cost obesity telehealth platforms that prescribe medication to all subscribers, offering a value proposition centered on patient safety and clinical rigor.

Overcoming regulatory and marketing barriers by obtaining LegitScript certification

One of the key challenges for obesity treatment platforms is exposure on major online advertising platforms and secure payment approvals. Meant Health has addressed this by obtaining LegitScript certification. This certification is a recognized standard that verifies compliance with stringent state-by-state medical licensing requirements and proper prescription procedures in the United States. This achievement provides a significant competitive advantage by overcoming marketing restrictions on channels such as Meta and Google, and it establishes a stable foundation for survival in the increasingly regulated telehealth environment.

Introducing a medication adherence package for holistic care

Meant Health's program provides patients with more than just self-administered injections; it integrates continuous feedback from dedicated care coaches and a supplementary kit to alleviate side effects. This multi-faceted approach aims to reduce the number of patients who discontinue treatment due to medication side effects and increase long-term weight loss success rates, thereby maximizing patient lifetime value. By offering an integrated solution that promotes dietary improvements while reducing reliance on medication, Meant Health aims to position itself as a long-term healthcare partner.